Previous Close | 18.68 |
1-Year Change | -12.75% |
6-Months Change | -8.39% |
3-Months Change | -20.78% |
Moving Avg (50d) | 22.303 |
Moving Avg (200d) | 20.872 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 0.867B |
Beta (3-Years) | 0.95 |
Revenue Growth (ttm) | -7.14% |
Net Profit Margin (ttm) | -8.13% |
Return On Assets (ttm) | -3.21% |
EPS (ttm) | -1.19 |
PE Ratio (ttm) | -15.7 |
Dividend Yield | % |
Asset Description: | Avanos Medical, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-05 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
18.228 | 17.67 | 17.298 | 16.74 | 15.81 | 14.88 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.